ADR-001

· Rohto Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ADR-001, covering 2023-07-06 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection [Phase 1]